Teva Pharmaceutical Industries Ltd. (TEVA)
37.36
-0.74
(-1.93%)
USD |
NYSE |
Aug 26, 10:52
Teva Pharmaceutical Industries 1 Year Total Returns (Daily) : 110.3% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 110.3% |
| August 24, 2026 | 100.1% |
| August 21, 2026 | 98.62% |
| August 20, 2026 | 109.0% |
| August 19, 2026 | 113.4% |
| August 18, 2026 | 102.5% |
| August 17, 2026 | 104.1% |
| August 14, 2026 | 109.6% |
| August 13, 2026 | 112.2% |
| August 12, 2026 | 121.3% |
| August 11, 2026 | 122.2% |
| August 10, 2026 | 120.8% |
| August 07, 2026 | 117.1% |
| August 06, 2026 | 117.4% |
| August 05, 2026 | 121.0% |
| August 04, 2026 | 119.4% |
| August 03, 2026 | 124.1% |
| July 31, 2026 | 126.6% |
| July 30, 2026 | 110.4% |
| July 29, 2026 | 109.9% |
| July 28, 2026 | 91.82% |
| July 27, 2026 | 87.91% |
| July 24, 2026 | 88.67% |
| July 23, 2026 | 88.06% |
| July 22, 2026 | 85.08% |
| Date | Value |
|---|---|
| July 21, 2026 | 92.21% |
| July 20, 2026 | 93.03% |
| July 17, 2026 | 96.38% |
| July 16, 2026 | 101.2% |
| July 15, 2026 | 96.76% |
| July 14, 2026 | 93.79% |
| July 13, 2026 | 96.22% |
| July 10, 2026 | 99.33% |
| July 09, 2026 | 98.08% |
| July 08, 2026 | 99.88% |
| July 07, 2026 | 105.6% |
| July 06, 2026 | 107.5% |
| July 02, 2026 | 103.2% |
| July 01, 2026 | 101.0% |
| June 30, 2026 | 102.1% |
| June 29, 2026 | 98.75% |
| June 26, 2026 | 100.5% |
| June 25, 2026 | 97.76% |
| June 24, 2026 | 100.2% |
| June 23, 2026 | 95.70% |
| June 22, 2026 | 89.97% |
| June 18, 2026 | 84.53% |
| June 17, 2026 | 92.78% |
| June 16, 2026 | 88.06% |
| June 15, 2026 | 98.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | 57.69% |
| Eli Lilly & Co. | 78.54% |
| Bristol Myers Squibb Co. | 50.95% |
| RedHill Biopharma Ltd. | -55.83% |
| MediWound Ltd. | -24.81% |